| Literature DB >> 27536093 |
Iraj Poureslami1, Susan Kwan2, Stephen Lam3, Nadia A Khan4, John Mark FitzGerald5.
Abstract
BACKGROUND: Patient education is a key component in the management of chronic obstructive pulmonary disease (COPD). Delivering effective education to ethnic groups with COPD is a challenge. The objective of this study was to develop and assess the effectiveness of culturally and linguistically specific audiovisual educational materials in supporting self-management practices in Mandarin- and Cantonese-speaking patients.Entities:
Keywords: COPD; Chinese community; cultural background; educational material; self-efficacy; self-management
Mesh:
Substances:
Year: 2016 PMID: 27536093 PMCID: PMC4976815 DOI: 10.2147/COPD.S105408
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Patient enrollment and attrition.
Abbreviation: COPD, chronic obstructive pulmonary disease.
Characteristics of study sample (n=91)
| Characteristic | n (%) |
|---|---|
| Study and control groups | |
| Group 1 (watched clinical video) | 22 (24.2) |
| Group 2 (watched lay video) | 26 (28.5) |
| Group 3 (watched both videos) | 29 (31.8) |
| Group 4 (read pamphlet) | 14 (15.4) |
| Sex | |
| Female | 20 (21.9) |
| Male | 71 (78.1) |
| Age | |
| ≤75 years old | 37 (40.7) |
| >75 years old | 54 (59.3) |
| Language | |
| Mandarin | 18 (19.8) |
| Cantonese | 73 (80.2) |
| Education | |
| Low education | 42 (46.2) |
| High education | 49 (53.8) |
| Disease severity | |
| GOLD Stage I: Mild (FEV1 ≥ 80% predicted) | 5 (5.5) |
| GOLD Stage II: Moderate (FEV1≥ 50 to <80% predicted) | 31 (34.0) |
| GOLD Stage III: Severe (FEV1 ≥30 to <50% predicted) | 46 (50.6) |
| GOLD Stage IV: Very severe (FEV1 <30% predicted) | 9 (9.9) |
| Current smokers | 40 (44) |
| Medications taken at home | |
| Long-acting anticholinergic | 55 (61.5) |
| ICS | 12 (13.2) |
| Short-acting bronchodilators | 76 (83.6) |
| LABA | 9 (9.9) |
| Combination of ICS and LAB | 79 (86.8) |
| Other medications | 17 (18.7) |
| COPD action plan | |
| Never received written action plan from doctor | 69 (75.8) |
| Had received verbal information from doctor | 16 (17.6) |
| Had received written action plan from doctor | 6 (6.6) |
Notes:
Median age of the participants was 75 years.
Low education, less than high school diploma, including those with no formal education. High education, a minimum of high school diploma.
Abbreviations: GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; LABA, long-acting β-agonists; COPD, chronic obstructive pulmonary disease.
Inhaler technique – overall improvement in correct use and distinguishing inhalers, from baseline assessment to 3 months postintervention
| Outcomes of interest (comparison of baseline assessment and 3-month postintervention assessment) | Mean difference from reference (95% CI) | Degrees of freedom | ||
|---|---|---|---|---|
| 1. Correct use | ||||
| Group 1 compared to Group 4 | 2.34 (1.34, 3.34) | 4.66 | 1.82 | <0.001 |
| Group 2 compared to Group 4 | 1.92 (0.91, 2.93) | 3.77 | 1.82 | <0.001 |
| Group 3 compared to Group 4 | 2.13 (1.08, 3.18) | 4.04 | 1.82 | <0.001 |
| Education (low vs high) | −0.59 (−1.16, −0.03) | −2.33 | 1.82 | <0.05 |
| Sex (male vs female) | 0.53 (0.04, 1.01) | 2.68 | 1.82 | <0.05 |
| Age (≤75 vs ≥76 years) | 0.19 (−0.25, 0.63) | 1.02 | 1.82 | N/S |
| Disease severity (very severe vs mild) | −0.56 (−1.67, 0.56) | 1.33 | 1.82 | N/S |
| 2. Differences between inhalers | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 0.18 (−0.14, 0.51) | 0.98 | 1.82 | N/S |
| Group 2 compared to Group 4 | 0.09 (−0.42, 0.33) | 0.51 | 1.82 | N/S |
| Group 3 compared to Group 4 | 0.20 (−0.44, 0.84) | 0.43 | 1.82 | N/S |
| Education (low vs high) | −0.11 (−0.44, 0.22) | −0.22 | 1.82 | N/S |
| Sex (male vs female) | −0.03 (−0.27, 0.21) | −0.36 | 1.82 | N/S |
| Disease severity | −0.17 (−0.72, 0.39) | 0.69 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | −0.35 (−0.69, –0.02) | −2.09 | 1.82 | <0.05 |
Note:
Inhaler technique improved significantly from pretest to 3-month postintervention follow-up at P<0.001.
Abbreviations: CI, confidence interval; N/S, not significant.
Inhaler technique: mean summary score out of 10
| Intervention group | Baseline
| 3-month follow-up
| ||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| Group 1 (watched clinical video) | 4.0 | 2.1 | 6.8 | 2.0 |
| Group 2 (watched lay video) | 4.5 | 2.0 | 5.9 | 2.0 |
| Group 3 (watched both videos) | 3.9 | 2.1 | 5.8 | 1.6 |
| Group 4 (read pamphlet) | 4.8 | 2.3 | 5.2 | 1.4 |
| All patients | 4.4 | 2.0 | 6.3 | 1.8 |
Abbreviation: SD, standard deviation.
Self-efficacy – overall improvement from baseline assessment to 3 months postintervention
| Outcomes of interest (comparison of baseline assessment and 3-month postintervention assessment) | Mean difference from reference (95% CI) | Degrees of freedom | ||
|---|---|---|---|---|
| 1. Prepared to manage COPD exacerbation | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 1.2 (0.38, 2.02) | 2.91 | 1.82 | <0.01 |
| Group 2 compared to Group 4 | 0.96 (0.09, 1.82) | 2.09 | 1.82 | <0.05 |
| Group 3 compared to Group 4 | 0.87 (0.04, 1.71) | 2.20 | 1.82 | <0.05 |
| Education (low vs high) | −0.56 (−1.30, 0.19) | −0.74 | 1.82 | N/S |
| Sex (male vs female) | −0.03 (−0.27, 0.21) | −0.04 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | 0.25 (−0.24, 0.75) | 0.85 | 1.82 | N/S |
| Disease severity | 0.10 (−1.13, 1.34) | 0.61 | 1.82 | N/S |
| 2. Perception of being informed about COPD | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 0.53 (−0.21, 1.28) | 0.69 | 1.82 | N/S |
| Group 2 compared to Group 4 | 0.36 (−0.40, 1.13) | 0.91 | 1.82 | N/S |
| Group 3 compared to Group 4 | 0.12 (−0.65, 0.90) | 1.93 | 1.82 | <0.05 |
| Age (≤75 vs ≥76 years) | −0.42 (−0.74, –0.06) | −1.73 | 1.82 | <0.05 |
| Education (low vs high) | −0.59 (−1.11, –0.09) | −1.98 | 1.82 | <0.05 |
| Sex (male vs female) | −0.10 (−0.48, 0.27) | −0.71 | 1.82 | N/S |
| Disease severity | 0.58 (−0.28, 1.44) | 0.58 | 1.82 | N/S |
| 3. Remain calm when facing a COPD worsening | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 0.40 (−0.38, 1.18) | 1.35 | 1.82 | N/S |
| Group 2 compared to Group 4 | 0.80 (0.02, 1.58) | 2.72 | 1.82 | <0.05 |
| Group 3 compared to Group 4 | 0.28 (−0.54, 1.11) | 1.55 | 1.82 | N/S |
| Education (low vs high) | −0.18 (−0.72, 0.37) | −1.18 | 1.82 | N/S |
| Sex (male vs female) | 0.33 (0.02, 0.65) | 2.12 | 1.82 | <0.05 |
| Age (≤75 vs ≥76 years) | 0.24 (−0.12, 0.60) | 0.90 | 1.82 | N/S |
| Disease severity | −0.34 (−1.24, 0.55) | 0.82 | 1.82 | N/S |
| 4. Ability to achieve goals in managing COPD | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 1.28 (0.36, 2.19) | 2.02 | 1.82 | <0.05 |
| Group 2 compared to Group 4 | 0.93 (−0.02, 0.88) | 1.62 | 1.82 | N/S |
| Group 3 compared to Group 4 | 1.05 (0.08, 2.02) | 1.98 | 1.82 | <0.05 |
| Education (low vs high) | −0.78 (−1.54, −0.01) | −2.69 | 1.82 | <0.05 |
| Sex (male vs female) | −0.05 (−0.60, 0.49) | 0.06 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | 0.27 (−0.24, 0.77) | 1.39 | 1.82 | N/S |
| Disease severity | −0.88 (−2.13, 0.37) | 0.94 | 1.82 | N/S |
| 5. Ability to self-manage COPD symptoms | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 0.14 (−0.61, 0.90) | 1.09 | 1.82 | N/S |
| Group 2 compared to Group 4 | 0.24 (−0.54, 1.02) | 1.03 | 1.82 | N/S |
| Group 3 compared to Group 4 | 0.38 (−1.18, 0.41) | 1.96 | 1.82 | <0.05 |
| Sex (male vs female) | −0.44 (−0.87, –0.02) | −1.04 | 1.82 | <0.05 |
| Education (low vs high) | −0.29 (−0.87, 0.30) | −0.99 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | −0.08 (−0.47, 0.31) | −0.31 | 1.82 | N/S |
| Disease severity | 0.68 (−0.29, 1.64) | 1.19 | 1.92 | N/S |
Notes:
Prepared to manage COPD exacerbation improved significantly from pretest to 3-month postintervention follow-up at P<0.001.
Being informed improved significantly from pretest to 3-month postintervention follow-up at P<0.05.
Remain calm improved significantly from pretest to 3-month postintervention follow-up at P<0.05.
Achieve goals in managing COPD improved significantly from pretest to 3-month postintervention follow-up at P<0.001.
Abbreviations: COPD, chronic obstructive pulmonary disease; CI, confidence interval; N/S, not significant.
Comprehension: overall improvement in understanding pulmonary rehabilitation procedures and steps to manage COPD, from baseline assessment to 3 months postintervention
| Outcomes of interest (comparison of baseline assessment and 3-month postintervention assessment) | Mean difference from reference (95% CI) | Degrees of freedom | ||
|---|---|---|---|---|
| 1. Understanding pulmonary rehabilitation procedures | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 2.14 (0.73, 3.16) | 2.05 | 1.82 | <0.05 |
| Group 2 compared to Group 4 | 2.22 (0.86, 3.30) | 2.24 | 1.82 | <0.05 |
| Group 3 compared to Group 4 | 0.30 (−0.76, 1.36) | 1.72 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | 0.81 (0.22, 1.41) | 2.75 | 1.82 | <0.01 |
| Education (low vs high) | −0.65 (−1.32, –0.02) | −2.53 | 1.82 | <0.05 |
| Sex (male vs female) | −0.18 (−0.84, 0.48) | −0.46 | 1.82 | N/S |
| Disease severity | −0.60 (−2.11, 0.91) | 1.11 | 1.82 | N/S |
| 2. Understanding steps to manage COPD | Overall improvement from baseline assessment to 3 months postintervention | |||
| Group 1 compared to Group 4 | 0.08 (−0.94, 0.79) | 0.42 | 1.82 | N/S |
| Group 2 compared to Group 4 | 0.02 (−0.87, 0.92) | 0.59 | 1.82 | N/S |
| Group 3 compared to Group 4 | 0.29 (−0.62, 1.20) | 0.23 | 1.82 | N/S |
| Education (low vs high) | −0.10 (−0.69, 0.49) | −0.66 | 1.82 | N/S |
| Sex (male vs female) | 0.08 (−0.34, 0.51) | 0.39 | 1.82 | N/S |
| Age (≤75 vs ≥76 years) | 0.30 (−0.09, 0.68) | 1.45 | 1.82 | N/S |
| Disease severity | 0.10 (−0.88, 1.07) | 1.69 | 1.82 | N/S |
Note:
Understanding steps improved significantly from pretest to 3-month postintervention follow-up at P<0.05.
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; N/S, not significant.